Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash Flows From Operating Activities:
Net loss	$ (61,129)	$ (84,049)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	38,867	75,048
Amortization of debt issuance costs and discounts	1,324	1,335
Loss on early extinguishment of debt and write-off of discounts and debt issuance costs	8,020
Loss on sale or disposal of assets	1,739	6,502
Loss on derivatives		1
Deferred benefit from income tax	(41,801)	(49,957)
Equity-based compensation	4,114	29,590
Changes in assets and liabilities:
Accounts receivable	(5,055)	(5,443)
Inventories	(4,812)	(7,451)
Prepaid expenses and other current assets	(4,046)	(2,884)
Accounts payable	27,198	8,760
Accrued salaries, wages and benefits	(3,332)	5,024
Deferred revenue	54,875	54,271
Other accrued expenses	(12,087)	866
Other assets and liabilities	1,817	618
Net cash provided by operating activities	5,692	32,231
Cash Flows From Investing Activities:
Capital expenditures	(56,853)	(47,846)
Change in restricted cash	(950)	344
Net cash used in investing activities	(57,803)	(47,502)
Cash Flows From Financing Activities:
Proceeds from issuance of debt	998,306
Repayments of long-term debt	(1,006,336)	(4,212)
Proceeds from draw on revolving credit facility	60,649	60,000
Repayments of revolving credit facility	(20,000)
Debt issuance costs	(15,390)
Dividends paid to stockholders	(110)	(17,674)
Payment of tax withholdings on equity-based compensation through shares withheld	(749)	(334)
Exercise of stock options		12
Net cash provided by financing activities	16,370	37,792
Change in Cash and Cash Equivalents	(35,741)	22,521
Cash and Cash Equivalents—Beginning of period	68,958	18,971
Cash and Cash Equivalents—End of period	33,217	41,492
Supplemental Disclosures of Noncash Investing and Financing Activities
Capital expenditures in accounts payable	12,237	41,567
Dividends declared, but unpaid	$ 815	$ 21,807